Die Arzneimittelbehörde Großbritanniens (MHRA) gab am Donnerstag grünes Licht für das Medikament Molnupiravir. (Archivbild) | Heute.at

Die Arzneimittelbehörde Großbritanniens (MHRA) gab am Donnerstag grünes Licht für das Medikament Molnupiravir. (Archivbild)

via REUTERS

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS ATTENTION EDITORS - THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. THIS IMAGE WAS PROCESSED BY REUTERS TO ENHANCE QUALITY, AN UNPROCESSED VERSION HAS BEEN PROVIDED SEPARATELY.